Skip to main content

Author: Doug Campbell

VUMC to support $170 million NIH nutrition research initiative

Jan. 20, 2022—  by Paul Govern The National Institutes of Health (NIH) has announced it will award $170 million over five years to clinics and centers across the country to study individual responses to food and dietary routines and develop electronic algorithms to support personalized nutrition recommendations. The program, called Nutrition for Precision Health (NPH), will recruit...

Read more


Grant boosts vaccine effectiveness research

Jan. 6, 2022—by Nancy Humphrey Investigators at Vanderbilt University Medical Center have received a $10.7 million research award from the Centers for Disease Control and Prevention (CDC) to continue the IVY Research Network, originally created in 2019 to look at how well flu vaccines work at preventing severe flu illness, and expanded in 2021 to enroll patients...

Read more


Opioid use disorder treatment access increases in areas with large Medicaid population

Jan. 4, 2022—  by Jill Clendening Researchers report that in communities where Medicaid is a more common source of insurance, providers of buprenorphine, an effective treatment for opioid use disorder (OUD), are much less likely to discriminate between Medicaid and privately insured prospective patients, but patients with either type of coverage still face many barriers to obtaining...

Read more


Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

Dec. 21, 2021—  by Jill Clendening There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. An estimated 3 million to 6 million persons...

Read more


Year in Review 2021: A year of perseverance, achievement at VUMC

Dec. 16, 2021—The fight against COVID-19 carried on, but while the pandemic dominated the news in 2021, there were many other achievements that made headlines this year at Vanderbilt University Medical Center.

Read more


Vision foundation’s longtime support key to Penn’s research efforts

Dec. 9, 2021—  by Nancy Humphrey John S. Penn, PhD, has been named the inaugural holder of the Knights Templar Eye Foundation (KTEF) Directorship in Pediatric Vision Research at the Vanderbilt Eye Institute in honor of his contributions to the foundation and the field of vision research. Penn’s connection with the KTEF, which is committed to supporting...

Read more


Vanderbilt University Hospital named a Top Teaching Hospital nationally by the Leapfrog Group

Dec. 7, 2021—Vanderbilt University Hospital has been named a Top Teaching Hospital by the Leapfrog Group, a large coalition of public and private purchasers of employee health coverage that works to encourage health care safety, quality and affordability.

Read more


Surveys show VUMC patients value immediate online access to test results

Dec. 2, 2021—  by Paul Govern Vanderbilt University Medical Center patients are overwhelmingly in favor of having immediate electronic access to their clinical test results, recent surveys show. A federal rule in effect since April 5 was designed in part to ensure that patients are given electronic access to their health information upon their request and at no cost, including, with very few exceptions,...

Read more


Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

Dec. 2, 2021—  by Bill Snyder The global biopharmaceutical company AstraZeneca announced more good news about its long-acting combination of two monoclonal antibodies against COVID-19 that were discovered at Vanderbilt University Medical Center. In a prevention trial, one prophylactic, intramuscular injection of the antibody combination, called AZD7442, reduced the risk of symptoms occurring after exposure to the...

Read more


Directorships honor VUMC leaders and philanthropic partners

Dec. 2, 2021—Ten Vanderbilt University Medical Center leaders from across the enterprise in clinical care, research, education and administration have been named as holders of endowed directorships.

Read more


Thyroid cancer paper lands national recognition

Dec. 2, 2021—by Tom Wilemon A group of investigators in the Endocrine Neoplasia Research Laboratory at Vanderbilt University Medical Center has received national recognition for their work to discover better treatments for thyroid cancer. A paper describing their lab work was awarded first place in the Basic Science category at the 2021 Cancer Research Competition, which promotes...

Read more


Study links depression scores, white blood cell count

Dec. 2, 2021—  by Emily Stembridge Researchers across four health care systems, including Vanderbilt University Medical Center, have found that increased depression polygenic scores are associated with increased white blood cell count, highlighting the importance of the immune system in the etiology of depression. Despite a wide understanding of depression as a psychiatric disorder, depression’s underlying biological...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more